Laurion Capital Management’s Boston Scientific BSX Stock Holding History

Laurion Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,528	Closed	-$1.06M	–	405
2025 Q1	$1.06M	Buy	+10,528	New	+$1.06M	0.03%	172
2024 Q3	–	Sell	-4,491	Closed	-$346K	–	327
2024 Q2	$346K	Buy	+4,491	New	+$329K	﹤0.01%	400
2022 Q4	–	Sell	-64,949	Closed	-$2.52M	–	428
2022 Q3	$2.52M	Buy	64,949 +168	+0.3%	+$6.74K	0.01%	309
2022 Q2	$2.41M	Buy	64,781 +56,416	+674%	+$2.3M	0.04%	217
2022 Q1	$370K	Buy	+8,365	New	+$363K	﹤0.01%	411
2021 Q4	–	Sell	-4,500	Closed	-$195K	–	570
2021 Q3	$195K	Sell	4,500 -9,400	-68%	-$416K	﹤0.01%	636
2021 Q2	$594K	Sell	13,900 -2,601	-16%	-$109K	﹤0.01%	496
2021 Q1	$638K	Sell	16,501 -16,358	-50%	-$619K	﹤0.01%	555
2020 Q4	$1.18M	Sell	32,859 -248,055	-88%	-$8.94M	0.01%	393
2020 Q3	$10.7M	Buy	280,914 +250,914	+836%	+$9.67M	0.13%	159
2020 Q2	$1.05M	Sell	30,000 -131,100	-81%	-$4.72M	0.01%	423
2020 Q1	$5.26M	Buy	+161,100	New	+$6.29M	0.06%	241
2019 Q3	–	Sell	-971,019	Closed	-$41.1M	–	1025
2019 Q2	$41.7M	Buy	+971,019	New	+$37.3M	0.41%	65
2019 Q1	–	Sell	-39,129	Closed	-$1.38M	–	879
2018 Q4	$1.38M	Buy	+39,129	New	+$1.42M	0.02%	492
2017 Q4	–	Sell	-6,000	Closed	-$165K	–	1545
2017 Q3	$175K	Sell	6,000 -28,800	-83%	-$795K	﹤0.01%	1455
2017 Q2	$965K	Buy	34,800 +20,300	+140%	+$539K	0.01%	1042
2017 Q1	$361K	Sell	14,500 -8,700	-38%	-$212K	﹤0.01%	1016
2016 Q4	$502K	Buy	+23,200	New	+$506K	﹤0.01%	829
2016 Q3	–	Sell	-680,800	Closed	-$15.9M	–	910
2016 Q2	$15.9M	Buy	+680,800	New	+$14.7M	0.25%	112
2016 Q1	–	Sell	-18,100	Closed	-$334K	–	806
2015 Q4	$334K	Sell	18,100 -25,600	-59%	-$459K	﹤0.01%	633
2015 Q3	$717K	Buy	+43,700	New	+$747K	0.01%	409

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Laurion Capital Management's BSX Position: Q2 2025 in Review

Laurion Capital Management sold out of Boston Scientific (BSX) in Q2 2025, closing a stake of 10,528 shares — an estimated $1.06M sold.

Laurion Capital Management first reported a position in BSX in Q3 2015 and held it in 21 quarters. The position peaked at $41.7M in Q2 2019. 1,688 funds tracked by Wall St. Rank hold BSX as of Q2 2025.

Laurion Capital Management reported no remaining Boston Scientific position as of Q2 2025 after selling out during the quarter.
Laurion Capital Management sold 10,528 Boston Scientific shares in Q2 2025, an estimated $1.06M.
Laurion Capital Management first reported a position in Boston Scientific in Q3 2015 and held it in 21 quarters.
Laurion Capital Management's Boston Scientific position peaked at $41.7M in Q2 2019.
1,688 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.

Based on Laurion Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.